Monitoring antiretroviral therapy in low and middle-income countries: current status and future considerations

AIDS. 2022 Nov 15;36(14):2071-2073. doi: 10.1097/QAD.0000000000003381.

Authors

Mauro Zaccarelli¹, Victor Musiime², Miguel E Quiñones-Mateu³

Affiliations

¹ HIV/Infectious Diseases Unit, "Villa Maraini" Foundation, Rome/Infectious Diseases Unit, "San Camillo de Lellis" Hospital, Rieti, Italy.
² Department of Paediatrics and Child Health, School of Medicine, College of Health Sciences, Makerere University/Research Department, Joint Clinical Research Centre, Kampala, Uganda.
³ Department of Microbiology & Immunology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand.

PMID: 36305186
DOI: 10.1097/QAD.0000000000003381

No abstract available

Publication types

Editorial
Comment

MeSH terms

Anti-HIV Agents* / therapeutic use
Developing Countries
HIV Infections* / drug therapy
Humans
Income

Substances

Anti-HIV Agents